Navigation Links
OPKO Completes Acquisition Of PROLOR Biotech
Date:8/29/2013

as risks inherent in funding, developing and obtaining regulatory approvals of new, commercially-viable and competitive products and treatments. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, and patent positions and litigation, among other factors. The forward-looking statements contained in this press release may become outdated over time. OPKO and PROLOR do not assume any responsibility for updating any forward-looking statements.OPKO CONTACT:

PROLOR CONTACT:

PROLOR MEDIA:Steve D. Rubin, Executive

Shai Novik, President

Barbara LindheimVice President - Administration

PROLOR Biotech, Inc.

BLL Partners, LLCJuan F. Rodrigez, Chief Financial Officer

+1 866 644-7811

+1 212 584-2276 +1 305-575-4100

shai@prolor-biotech.com 

blindheim@bllbiopartners.comOPKO Heath, Inc.
'/>"/>

SOURCE OPKO Health, Inc.; PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sleep Nation, Inc. Completes 43 Acquisitions
2. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
3. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
4. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
5. MicuRx Completes $25 Million Series B Financing
6. Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
7. ULURU Inc. Completes Redemption Of Preferred Stock
8. HedgePath Pharmaceuticals, Inc. Completes Reorganization Plan with Commonwealth Biotechnologies
9. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
10. Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
11. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... 24, 2011 Molecular Devices, Inc. and ChanTest Corporation, ... tools and solutions, have signed an agreement for Molecular ... and GPCR cell lines on a non-exclusive basis.  As ... ChanTest,s ion channel and GPCR cell lines and promote ...
... MELVILLE, N.Y., March 24, 2011 Henry Schein, Inc. ... health care products and services to office-based dental, medical ... the "Wholesalers:  Health Care" industry in Fortune ... the categories of Social Responsibility and Global Competitiveness.  The ...
Cached Medicine Technology:Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement 2Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement 3Henry Schein Ranks #1 in Its Industry for Social Responsibility as a Fortune 2011 World's Most Admired Company 2Henry Schein Ranks #1 in Its Industry for Social Responsibility as a Fortune 2011 World's Most Admired Company 3
(Date:4/17/2014)... the first genetic variant specifically associated with the ... around 10-15 per cent of all breast cancer ... breast cancer sub-type, called invasive lobular carcinoma, gives ... this particular kind of breast cancer, which can ... today (Thursday) in the journal PloS Genetics ...
(Date:4/17/2014)... April issue of Experimental Biology and Medicine ... Rex Gaskins and Paul Kenis in the Institute ... the University of Illinois Urbana-Champaign describe their recent ... underlie a variety of cell functions including energy ... crucial roles in regulating normal cellular behavior, redox ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... It,s estimated that as many as 10 million older ... of loneliness and isolation. , However, new research ... retired older Americans for six years found that ... of depression by more than 30 percent. , "That,s ... State University professor of telecommunication, information studies and media ...
(Date:4/17/2014)... from Boston University School of Medicine (BUSM) have ... consumption in an experimental model. The findings, reported ... Alcohol Abuse , may lead to more effective ... is one of the leading causes of illness ... negative economic impact by limiting the productivity of ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... damage to DNA, study says , , THURSDAY, Dec. ... at risk of DNA damage from prolonged exposure to ... 83 airline pilots to 50 university faculty members from ... participants were analyzed for DNA abnormalities, specifically the number ...
... teens is slowing, survey finds , , THURSDAY, Dec. 11 (HealthDay ... teens, the abuse of painkillers such as Vicodin and Oxycontin ... in the use of drugs such as marijuana has stalled ... Institute on Drug Abuse says in its report, Monitoring ...
... The American Academy of Orthopaedic Surgeons (AAOS) has ... of Osteoarthritis of the Knee". These guidelines were explicitly ... knee replacement surgery. While a wide range of treatment ... patients after discussions with their physicians. , ...
... Growth Equities, Ltd. initiates coverage of PolyMedix Inc. (OTC ... $9.00 price target. PolyMedix focuses on developing novel ... The Company,s leading clinical development programs include the ... , , Emerging Growth ...
... President & CEO , , ... a drug delivery technology company, today announced that George DeMott, chairman ... position as chairman, effective immediately. Mr. DeMott will continue to ... , , The board of directors ...
... serious risk of a long-term hospital stay, and ventilator-associated ... 15% of all people who are ventilated, is among ... a higher resistance to antibiotics, patients who rely on ... as 26,000 Americans do every year. , Thanks to ...
Cached Medicine News:Health News:Pilots May Face Greater Cancer Risk 2Health News:10% of U.S. High School Seniors Use Vicodin 2Health News:10% of U.S. High School Seniors Use Vicodin 3Health News:AAOS Issues New Clinical Practice Guideline for Osteoarthritis of the Knee 2Health News:AAOS Issues New Clinical Practice Guideline for Osteoarthritis of the Knee 3Health News:Emerging Growth Equities, Ltd. Initiates Coverage of PolyMedix Inc. With a Buy Rating and a $9.00 Price Target 2Health News:DelSite Chairman George DeMott Resigns 2Health News:DelSite Chairman George DeMott Resigns 3Health News:There's a life-saving medical device sitting on your sink 2
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... GYNECARE TVT is a minimally invasive, ... of stress urinary incontinence. GYNECARE TVT is ... of the urethra, and when needed, TVT ... the correct position. The procedure takes approximately ...
...
...
Medicine Products: